Antihemophilic and von Willebrand factor complex and Esketamine
Determining the interaction of Antihemophilic and von Willebrand factor complex and Esketamine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor / von willebrand factor
Brand name: Alphanate, Humate-P, Wilate, Wilstart, Dried Factor VIII Fraction Type 8Y, Haemate P, Optivate
Synonyms: Antihemophilic Factor/von Willebrand Factor Complex (Human)
Generic Name: esketamine
Brand name: Spravato
Synonyms: Esketamine (nasal)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antihemophilic and von Willebrand factor complex-Esketamine Hydrochloride
- Antihemophilic and von Willebrand factor complex-Esketamine nasal
- Antihemophilic and von Willebrand factor complex-Eslicarbazepine
- Antihemophilic and von Willebrand factor complex-Eslicarbazepine Acetate
- Antihemophilic and von Willebrand factor complex-Esmolol
- Antihemophilic and von Willebrand factor complex-Esmolol HCl
- Esketamine-Antihemophilic Factor (Recombinant [Fc Fusion Protein])
- Esketamine-Antihemophilic Factor (Recombinant [Pegylated-aucl])
- Esketamine-Antihemophilic Factor (Recombinant [Pegylated])
- Esketamine-Antihemophilic Factor (Recombinant [Pegylated]) Injection
- Esketamine-Antihemophilic Factor (Recombinant [Porcine Sequence])
- Esketamine-Antihemophilic Factor (Recombinant) (Advate)